Clinical and surgical factors affecting the prognosis and survival rates in patients with mucormycosis
- PMID: 34075487
- DOI: 10.1007/s00405-021-06910-6
Clinical and surgical factors affecting the prognosis and survival rates in patients with mucormycosis
Abstract
Purpose: To investigate the factors affecting disease specific mortality (DSM) in patients with mucormycosis.
Methods: This retrospective study included 24 patients diagnosed with mucormycosis and who had undergone surgical and medical treatment between 2010 and 2020. There were 14 male and 10 female patients whose mean age was 53.70 ± 16.87 years, range 18-83. We reviewed the factors affecting DSM, including the extent of disease (paranasal sinus, palatal, orbital or intracranial involvement) and blood parameters (BP) that are serum glucose level (SGL), white blood cell, neutrophil, lymphocyte counts, C-reactive protein and hemoglobulin levels. Also, the effect of SGL in diabetes mellitus and BP in hematological malignancies on DSM was additionally evaluated.
Results: Orbital (p = 0.001) and intracranial (p < 0.01) involvement had statistically significant effect on DSM but not the palatal involvement. When Cox regression analysis was employed to analyze the effect of multiple independent factors on DSM, only the extent of disease (p = 0.023) had statistically significant effect. Receiver operating characteristic analysis of SGL for diabetic patients demonstrated that the area under the curve was 0.917 (p = 0.016). A cut-off SGL of 360 mg/dl revealed an 83.3% sensitivity and 83.3% specificity for mortality outcome for diabetic patients having mucormycosis.
Conclusion: Orbital or cerebral involvement is related to a poor prognosis, so early endoscopic nasal examination, diagnosis and treatment are of vital importance for DSM in mucormycosis. Serum glucose level over 360 mg/dl in uncontrolled diabetic patients with fever, ophthalmological findings and facial hypoesthesia should necessitate a consultation to an otolaryngologist and an endoscopic careful nasal examination.
Keywords: Diabetes mellitus; Hematologic malignancy; Invasive fungal rhinosinusitis; Mortality; Mucormycosis; Prognosis.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Similar articles
-
Invasive Fungal Rhinosinusitis: Clinical and Surgical Factors Affecting Its Prognosis and Disease-Specific Morality.Cureus. 2023 May 10;15(5):e38830. doi: 10.7759/cureus.38830. eCollection 2023 May. Cureus. 2023. PMID: 37303322 Free PMC article.
-
Rhino-Orbito-Cerebral Mucormycosis in Diabetic Disease Mucormycosis in Diabetic Disease.J Craniofac Surg. 2020 Jun;31(4):e321-e324. doi: 10.1097/SCS.0000000000006191. J Craniofac Surg. 2020. PMID: 32028364
-
Outcomes and factors affecting them in patients with rhino-orbito-cerebral mucormycosis.Br J Ophthalmol. 2019 Oct;103(10):1460-1465. doi: 10.1136/bjophthalmol-2018-312688. Epub 2018 Dec 4. Br J Ophthalmol. 2019. PMID: 30514712
-
[Paranasal mucormycosis with involvement of the sphenoid sinus].Rev Stomatol Chir Maxillofac. 1998 Apr;99(1):52-5. Rev Stomatol Chir Maxillofac. 1998. PMID: 9615356 Review. French.
-
Rhino-orbito-cerebral mucormycosis, a retrospective study of 7 cases.Acta Otorrinolaringol Esp. 2010 Jan-Feb;61(1):48-53. doi: 10.1016/j.otorri.2009.07.001. Epub 2009 Dec 10. Acta Otorrinolaringol Esp. 2010. PMID: 20004878 Review. English, Spanish.
Cited by
-
Successful treatment of rhino-cerebral mucormycosis with dual antifungal therapy and minimal surgical debridement.IDCases. 2022 Sep 6;30:e01615. doi: 10.1016/j.idcr.2022.e01615. eCollection 2022. IDCases. 2022. PMID: 36119757 Free PMC article.
-
Impact of risk factors in craniofacial mucormycosis.Med Oral Patol Oral Cir Bucal. 2025 Mar 1;30(2):e211-e216. doi: 10.4317/medoral.26789. Med Oral Patol Oral Cir Bucal. 2025. PMID: 39864087 Free PMC article.
-
More than meets the eye: rhino-orbital cerebral mucormycosis with diabetic ketoacidosis presenting as periorbital edema resulting in orbital exenteration and maxillectomy.Proc (Bayl Univ Med Cent). 2024 Feb 8;37(2):348-354. doi: 10.1080/08998280.2023.2298183. eCollection 2024. Proc (Bayl Univ Med Cent). 2024. PMID: 38343486 Free PMC article.
References
-
- Hosseini SMS, Borghei P (2005) Rhinocerebral mucormycosis: pathways of spread. Eur Arch Otorhinolaryngol 262:932–938. https://doi.org/10.1007/s00405-005-0919-0 - DOI - PubMed
-
- Kandemir Ö, Görür K, Şahin E, Özcan C, Apa DD (2007) The probable role of desferrioxsamine for rhinocerebral mucormycosis in a diabetic patient. Ankem Derg 21:238–241
-
- Gen R, Horasan EŞ, Vaysoğlu Y, Arpaci RB, Ersöz G, Özcan C (2013) Rhino-orbito-cerebral mucormycosis in patients with diabetic ketoacidosis. J Craniofac Surg 24:e144–e147. https://doi.org/10.1097/scs.0b013e31827c7eb8 - DOI - PubMed
-
- Roden MM, Zaoutis TE, Buchanan WL et al (2005) Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin Infect Dis 41:634–653. https://doi.org/10.1086/432579 - DOI - PubMed - PMC
-
- Kasapoglu F, Coskun H, Ozmen OA, Akalin H, Ener B (2010) Acute invasive fungal rhinosinusitis: evaluation of 26 patients treated with endonasal or open surgical procedures. Otolaryngol Head Neck Surg 143:614–620. https://doi.org/10.1016/j.otohns.2010.08.017 - DOI - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials